Atika Capital Management’s Elevance Health ELV Stock Holding History

Atika Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$6.04M	–	90
2019 Q4	$6.04M	Buy	+20,000	New	+$5.5M	1.17%	42
2019 Q1	–	Sell	-25,500	Closed	-$6.7M	–	79
2018 Q4	$6.7M	Buy	25,500 +500	+2%	+$137K	1.97%	17
2018 Q3	$6.85M	Buy	+25,000	New	+$6.49M	1.23%	27
2018 Q1	–	Sell	-16,500	Closed	-$3.71M	–	75
2017 Q4	$3.71M	Buy	+16,500	New	+$3.51M	1.44%	32
2014 Q4	–	Sell	-12,000	Closed	-$1.44M	–	69
2014 Q3	$1.44M	Buy	+12,000	New	+$1.38M	1.1%	39

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atika Capital Management's ELV Position: Q1 2020 in Review

Atika Capital Management sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 20,000 shares — an estimated $6.04M sold.

Atika Capital Management first reported a position in ELV in Q3 2014 and held it in 5 quarters. The position peaked at $6.85M in Q3 2018. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

Atika Capital Management reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
Atika Capital Management sold 20,000 Elevance Health shares in Q1 2020, an estimated $6.04M.
Atika Capital Management first reported a position in Elevance Health in Q3 2014 and held it in 5 quarters.
Atika Capital Management's Elevance Health position peaked at $6.85M in Q3 2018.
1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Atika Capital Management's 13F filing for Q1 2020, filed 14 May 2020.